Recently Updated
- 12/15/2009
- Medical Abortion Guidebook
- 11/05/2009
- List of Mifepristone Approval
- 11/04/2009
- Map of Mifepristone Approval
- 05/25/2009
- Clinical Studies List
- 05/04/2009
- Medical Abortion Program Brief
Misoprostol for Early Abortion
Misoprostol and Teratogenicity: Reviewing the Evidence
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol for Incomplete Abortion and Miscarriage
Medical Abortion Program Brief
Abortion in the Middle East and North Africa
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Annotated Bibliography - Misoprostol for Early Abortion
Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol: A New Addition to Post Abortion Care
Pregnancy Failure and Miscarriage Program Brief
Misoprostol for incomplete abortion in Tanzania
Sublingual misoprostol after mifepristone
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Postpartum Hemorrhage Program Brief
Expanding Choice in Abortion Services in Armenia
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Blood Loss After Vaginal Delivery
Mifepristone for late first trimester abortion
Sublingual misoprostol for incomplete abortion
FAQs on Fatal Infection and Medical Abortion - Technical Version
Misoprostol for Women’s Health
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Misoprostol PPH Treatment Study
FAQs on Fatal Infection and Medical Abortion - Summary
Postpartum Hemorrhage: Responding to the Challenge
Treatment of postpartum hemorrhage with misoprostol
Two distinct oral routes of misoprostol in mifepristone medical abortion
Route of Misoprostol Administration
PPH Prevention Study in Pakistan
Technical Assistance Activities Brief
PPH Misoprostol Adjunct Treatment Study
Materials Development Activities Brief
STIs/ HIV/ Infectious Disease Program Brief
Fever after treatment of postpartum hemorrhage
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Policy and Advocacy Activities Brief
Can mifepristone medical abortion be simplified?
Misoprostol to treat missed abortion in the first trimester
Use of sequential serum hCG and sonography for medical abortion only when indicated
Are two doses of misoprostol after mifepristone for early abortion better than one?
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
PPH Treatment Study in Pakistan
Social Science Research Activities Brief
Reference List - Misoprostol for Early Abortion
FAQ on Hormonal Contraception and HIV
Misoprostol for incomplete abortion in Burkina Faso
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Alternatives to mifepristone for early medical abortion
Perspectives on reproductive decision-making amongst HIV-infected individuals
Training and Education Activities Brief
Integrating medical abortion into safe abortion services in South Africa
Issue Brief on Hormonal Contraception and HIV
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Methotrexate compared to misoprostol alone for early medical abortion
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Reproductive intentions among HIV-positive women and men
Supervision for use of mifepristone medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Outlook Newsletter on Hormonal Contraception and HIV
Misoprostol for incomplete abortion in Mozambique
Relationship of Hormonal Contraception to HIV
Improving Current Therapies and Exploring New Options in Abortifacient Technology
The supreme court and the partial-birth abortion ban act of 2003
Regimens of misoprostol with mifepristone for early medical abortion
Clostridium sordellii infection in medical abortion
Mifepristone medical abortion in Albania
Abortion and sex determination
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Community-based kangaroo mother care to prevent neonatal and infant mortality
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Non-physician clinicians can safely provide first trimester medical abortion
Increasing women’s choices in medical abortion in Turkey
Annotated Bibliography - Mifepristone Medical Abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Comparison of serum markers for thrombophilia and autoimmune disease
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Home administration of misoprostol for early medical abortion in India
Alternatives to Routine Follow-Up for Early Medical Abortion